m+Medelevator.RU
← Поиск публикаций
Frontiers in oncology · 2026

A foundation model-based multi-instance learning framework for accurate prediction of lymph node metastasis in prostate cancer from whole slide images.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zeng Guang, Li Weiwei, Mei Haonan, Du Ran

Аннотация

BACKGROUND: Nodal involvement (N stage) is a key prognostic factor in prostate cancer (PCa). Conventional imaging and histopathology often have limited sensitivity and inter-observer variability. AI-based computational pathology, using multi-instance learning (MIL) and foundation models, offers a promising approach for accurate and interpretable N stage prediction from H&E-stained whole slide images (WSIs).

METHODS: In this multicenter retrospective study, we developed a weakly supervised deep learning framework integrating MIL with domain-adapted foundation model encoders (UNI-v2, CONCH, ResNet-50) to predict N stage. WSIs from 280 RHWU patients were used for training and 306 TCGA patients for external validation. Attention heatmaps enabled interpretability, while transcriptomic analyses explored molecular correlates via differential expression and bioinformation analysis.

RESULTS: The UNI-v2-based model achieved the highest performance (AUC 0.879 in RHWU, 0.850 in TCGA), surpassing CONCH and ResNet-50. Attention heatmaps highlighted tumor-stromal interfaces and poorly differentiated tumor clusters. Transcriptomic analysis identified 94 differentially expressed genes; upregulated genes were enriched in cell cycle, and immune pathways, while downregulated genes involved ion transport and metabolism.

CONCLUSIONS: This AI-MIL framework accurately predicts nodal involvement in PCa and provides biologically interpretable insights, supporting its potential as a precision oncology tool for risk stratification and treatment planning.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты